Schultz & Williams is proud to support the mission of the Alzheimer’s Drug Discovery Foundation, a New York-based nonprofit dedicated to accelerating the discovery of drugs to prevent, treat, and ultimately cure Alzheimer’s disease and related dementias. Founded in 1998 by Leonard A. and Ronald S. Lauder, the Foundation is uniquely focused on bridging critical gaps in drug development by funding early-stage research that might otherwise go unfunded. 

Through a venture philanthropy model, the Alzheimer’s Drug Discovery Foundation supports scientists around the globe working on innovative drug candidates, biomarkers, and prevention strategies, helping turn breakthroughs in Alzheimer’s science into tangible therapies. Their work not only advances promising treatments but also fosters collaboration within the scientific community to address one of the most pressing health challenges of our time.

We are honored to support their ongoing efforts to drive progress in Alzheimer’s research, expand access to cutting-edge science, and bring hope to millions of families affected by cognitive decline.

“We’re excited to help advance the work of the Alzheimer Drug Discovery Foundation.  Their unique approach to this work and venture philanthropy model offers promising treatments for this horrific disease.”

 

— Craig Shelley, CEO